Louis Picker, M.D., and his team have been awarded a $25 million grant from the Bill & Melinda Gates Foundation that will spur their work on a vaccine candidate against HIV. This work is based on previous findings that this candidate, which uses cytomegalovirus as a vector, can boost effector memory T cells to successfully target simian immunodeficiency virus. This new award will test the safety of a prototype human version of the vaccine in a phase I clinical trial in humans, as well as optimize the vaccine for phase II trials. Read the OHSU media release here, and here’s the Oregonian story.
Welcome to the Research News Blog
OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.
Recent Blog Posts
- Funding opportunity for women’s health research
- New OHSU research suggests possible target in fight against Alzheimer’s
- Oregon Hearing Research Center scientists featured on front page of the Oregonian
- Rachel Dresbeck on Data Jamboree panel presentation: Sharing data & software securely, Nov. 4
- Rachel Dresbeck on Jan. 1: New F&A rates for non-clinical, industry-sponsored research
- Dawn on Jan. 1: New F&A rates for non-clinical, industry-sponsored research
awards basic research brown bag cancer career development clinical research collaboration community conference cores Discoveries eIRB event events funding funding focus funding opportunities Funding Opportunity graduate students internal funding IRB Notes junior faculty lecture Limited Submission NIH NIH News OCTRI OHSU faculty OHSU Knight Cancer Institute OHSU Researchers ONPRC postdoctoral fellows research Research Administration research career development research integrity Research Resources research week seminar technology training translational research TTBD visiting speaker workshop